Tarr Mark J sold $21.7M of EHC
Tarr Mark J (President & CEO) sold 173,148 shares of Encompass Health Corp (EHC) at an average of $125.47 ($125.46–$126.06, $21.72M total) across 2 trades on 2026-08-10.
How this was made
The 30-second read
Why it matters
Traders may treat the CEO’s sizable open-market sale as a sentiment factor, especially because it was not under a 10b5-1 plan, but there is no fundamental company news included.
Market read
A new Form 4 reports a large CEO open-market sale at roughly $125.46 to $126.06 per share.
What to watch
The article does not include any accompanying earnings, guidance, or operational update, and it does not state whether other executives or directors also sold around the same time.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Encompass Health Corp.
Ticker impact
Encompass Health CEO Tarr Mark J sold about 173,148 shares in open-market transactions totaling $21.7M, per a new Form 4 filing.
Near-term sentiment drag is possible, but follow-through depends on whether other insiders also sell and on broader earnings guidance.
The filing discloses transaction size, price range, and that it was not under a pre-arranged 10b5-1 plan, but it provides no stated reason or company performance linkage.
Market effects
Limited read-through to the healthcare services sector; insider sales are company-specific signals without sector-wide catalysts in the text.
None indicated.
None indicated.
Counterpoint
The sale could be for diversification, taxes, or planned liquidity needs, and insider sales often do not predict near-term fundamentals.
Key entities
- issuerEncompass Health Corp
Subject of the Form 4 insider transaction disclosure.
- insiderTarr Mark J
President and CEO who sold shares totaling about $21.7M.
